# Monte Rosa Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jan 9, 2026

- Company: [Monte Rosa Therapeutics, Inc.](/companies/glue.md) (CIK 1826457)
- Form: SCHEDULE 13D/A
- Filed: 2026-01-09
- Accepted by EDGAR: Jan 9, 2026, 16:19 ET
- Period: not reported
- Accession: 0001193125-26-008951
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1826457/000119312526008951/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1826457/000119312526008951/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1826457/000119312526008951/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-008951. Last ingested by Listed: Nov 5, 2026, 11:59 ET. No prices; not investment advice.